Last updated: 19 July 2019 at 6:13am EST

Richard Mcamden Partners St... Net Worth




The estimated Net Worth of Richard Mcamden Partners St... is at least 2.91 百万$ dollars as of 11 July 2013. Richard St owns over 2,343 units of Atricure Inc stock worth over 1,081,272$ and over the last 11 years Richard sold ATRC stock worth over 1,826,885$.

Richard St ATRC stock SEC Form 4 insiders trading

Richard has made over 5 trades of the Atricure Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Richard sold 2,343 units of ATRC stock worth 23,430$ on 11 July 2013.

The largest trade Richard's ever made was selling 95,598 units of Atricure Inc stock on 13 June 2013 worth over 857,514$. On average, Richard trades about 40,469 units every 6 days since 2013. As of 11 July 2013 Richard still owns at least 40,196 units of Atricure Inc stock.

You can see the complete history of Richard St stock trades at the bottom of the page.



Insiders trading at Atricure Inc

Over the last 19 years, insiders at Atricure Inc have traded over 52,789,242$ worth of Atricure Inc stock and bought 666,621 units worth 5,937,195$ . The most active insiders traders include Scott William DrakeGroup I, Llc Donoghue Danie...Management Group Viii L L C.... On average, Atricure Inc executives and independent directors trade stock every 24 days with the average trade being worth of 548,410$. The most recent stock trade was executed by Maggie Yuen on 15 August 2024, trading 3,500 units of ATRC stock currently worth 84,245$.



What does Atricure Inc do?

atricure, inc. provides innovative technologies for the treatment of afib and related conditions. afib affects more than 33 million people worldwide. electrophysiologists and cardiothoracic surgeons around the globe use atricure technologies for the treatment of afib and reduction of afib related complications. atricure’s isolator® synergy™ ablation system is the first and only medical device to receive fda approval for the treatment of persistent afib. atricure’s atriclip left atrial appendage exclusion system products are the most widely sold laa management devices worldwide, with more than 100,000 implanted to date. for more information, visit atricure.com or follow us on twitter @atricure.



Complete history of Richard St stock trades at Atricure Inc

インサイダー
取引
取引
合計金額
Richard Mcamden Partners St...
販売 23,430$
11 Jul 2013
Richard Mcamden Partners St...
販売 262,958$
19 Jun 2013
Richard Mcamden Partners St...
販売 364,281$
17 Jun 2013
Richard Mcamden Partners St...
販売 857,514$
13 Jun 2013
Richard Mcamden Partners St...
販売 318,702$
11 Jun 2013


Atricure Inc executives and stock owners

Atricure Inc executives and other stock owners filed with the SEC include: